The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 420.00
Ask: 430.00
Change: -5.00 (-1.16%)
Spread: 10.00 (2.381%)
Open: 430.00
High: 432.00
Low: 422.50
Prev. Close: 430.00
MPAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Awards under Long Term Incentive Plan

12 Jun 2019 15:30

RNS Number : 0123C
Mpac Group PLC
12 June 2019
 

12 June 2019

 

Mpac Group plc

("Mpac" or the "Company")

Awards under Long Term Incentive Plan

 

Mpac Group plc (AIM: MPAC) announces that on 12 June 2019 its Executive Directors were granted the following share awards as conditional rights to acquire ordinary shares of 25p each in the Company ('Conditional Awards'):

Director Position Number of Shares

under Conditional Award

Dr A Steels Chief Executive 210,000

Mr W C Wilkins Group Finance Director 120,000

 

Further details relating to the operation of the Long Term Incentive Plan will be provided in the Company's 2019 Annual Report and Accounts.

Set out below are the notifications, made in accordance with the requirements of the EU Market Abuse Regulation, in relation to the grant of Conditional Awards.

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr A Steels - Chief Executive

2

Reason for the notification

a)

Position/status

See 1(a) above - Dr Steels is classified as a PDMR of the Company

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each ("Ordinary Shares")

GB0005991111

b)

Nature of the transaction

Conditional Award of ordinary shares pursuant to the rules of the Company's Long Term Incentive Plan.

The performance conditions for the awards relate to i) cumulative Earnings Per Share, and ii) average Return on Capital Employed, in each case over the three-year period ending 31 December 2021. Awards automatically vest, to the extent the performance conditions are met, at the end of the performance period. The awards are subject to a holding period of a further two years following vesting. The rights of the shares are deferred, such that any dividends and other distributions attaching to the shares between the date of the award and vesting do not form part of the award.

c)

Price(s) and volume(s)

Volume(s): Conditional Award over 210,000 shares

 

Price: £Nil

 

 

d)

Aggregated information

- Volume

 

- Price

 

- Total

N/A

e)

Date of the transaction

12 June 2019

f)

Place of the transaction

Outside a trading volume

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr W C Wilkins - Group Finance Director

2

Reason for the notification

a)

Position/status

See 1(a) above - Mr Wilkins is classified as a PDMR of the Company

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mpac Group plc

b)

LEI

213800J3KUDYLRHHU562

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each ("Ordinary Shares")

GB0005991111

b)

Nature of the transaction

Conditional Award of ordinary shares pursuant to the rules of the Company's Long Term Incentive Plan.

The performance conditions for the awards relate to i) cumulative Earnings Per Share, and ii) average Return on Capital Employed, in each case over the three-year period ending 31 December 2021. Awards automatically vest, to the extent the performance conditions are met, at the end of the performance period. The awards are subject to a holding period of a further two years following vesting. The rights of the shares are deferred, such that any dividends and other distributions attaching to the shares between the date of the award and vesting do not form part of the award.

c)

Price(s) and volume(s)

Volume(s): Conditional Award over 120,000 shares

 

Price: £Nil

 

 

d)

Aggregated information

- Volume

 

- Price

 

- Total

N/A

e)

Date of the transaction

12 June 2019

f)

Place of the transaction

Outside a trading volume

 

For further information, please contact:

Mpac Group plc Tel: +44 (0) 2476 421100

Duncan Tyler, Company Secretary

 

Panmure Gordon (UK) Limited (Nominated Advisor & Broker) Tel: +44 (0) 20 7886 2500

Dominic Morley

James Stearns

 

Hudson Sandler Tel: +44 (0) 20 7796 4133

Nick Lyon

Nick Moore

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKBDBQBKDAAD
Date   Source Headline
17th Apr 20247:00 amRNSLaunch of ESG Report
9th Apr 20241:12 pmRNSGrant of Options
8th Apr 20242:15 pmRNSNotice of AGM
19th Mar 20247:00 amRNSFull Year Results
21st Feb 20247:00 amRNSEquity Development Investor Presentation
16th Feb 20247:00 amRNSNotice of Results
11th Jan 20247:00 amRNSFull Year Trading Update
4th Dec 202311:51 amRNSDirector/PDMR Shareholding
27th Nov 202311:36 amRNSDirector/PDMR Dealing
18th Oct 20232:42 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSAppointment of Joint Broker
22nd Sep 202311:19 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSHalf Year Results
17th Aug 20237:00 amRNSEquity Development Investor Webinar
11th Jul 20237:00 amRNSTrading Update and Notice of Results
30th May 202310:52 amRNSDirector/PDMR Shareholding
18th May 202311:17 amRNSResult of Annual General Meeting
17th May 20237:00 amRNSAGM Statement
2nd May 20234:37 pmRNSDirector/PDMR Transaction
6th Apr 20235:30 pmRNSAvailability of Annual Report and Notice of AGM
27th Mar 202310:53 amRNSDirector/PDMR Dealing
22nd Mar 20237:01 amRNSCEO succession
22nd Mar 20237:00 amRNSFull Year Results
20th Feb 20237:00 amRNSEquity Development Investor Presentation
17th Feb 20237:00 amRNSNotice of Results
16th Jan 20237:00 amRNSFull Year Trading Update
24th Oct 20222:20 pmRNSDirectorate Appointment
14th Oct 202210:58 amRNSReplacement - PDMR Dealing & Total Voting Rights
12th Oct 20224:59 pmRNSDirector/PDMR Dealing & Total Voting Rights
15th Sep 202212:50 pmRNSMpac signs FREYR framework agreement
13th Sep 20227:00 amRNSEquity Development Investor Presentation
9th Sep 20222:16 pmRNSDirector/PDMR Transaction
8th Sep 20227:00 amRNSHalf Year Result
11th Jul 20227:00 amRNSTrading Update and Notice of Results
24th Jun 20222:54 pmRNSAppointment of new auditor
10th Jun 20224:10 pmRNSGrant of Options
27th May 20222:56 pmRNSDirectors/PDMRs Dealing
25th May 20224:13 pmRNSHolding(s) in Company
19th May 20223:57 pmRNSEBT Subscription & Total Voting Rights
13th May 20224:25 pmRNSDirectors/PDMRs Dealing - Replacement
12th May 20224:46 pmRNSDirectors/PDMRs Dealing
4th May 20224:16 pmRNSResult of AGM
4th May 20227:00 amRNSAGM Statement
17th Mar 20227:00 amRNSFull Year Results
14th Feb 20224:38 pmRNSNotice of Results
12th Jan 20227:00 amRNSFull Year Trading Update
21st Oct 20215:16 pmRNSDirectorate Appointment
2nd Sep 20217:00 amRNSHalf Year Results
13th Aug 20217:00 amRNSEquity Development Investor Webinar
27th Jul 20217:00 amRNSChange of Registered Office Address

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.